Delivery Order SPE2DB24D2013-SPE2DB25FCHMK
Award Date
2/27/25
Potential Completion Date
2/28/25
Potential Value
$35K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $68,193.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The contract has an ultimate completion date of January 30, 2025 and utilizes a Firm Fixed Price pricing structure. Amerisourcebergen holds a...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Fenofibrate 145 mg tablets, a cardiovascular medication, valued at $10,512.99 with a completion date of September 26, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,836.58, is for the delivery of Fenofibrate 145 mg tablets in quantities of 500 per bottle. The contract is a firm fixed-price delivery order with a period of performance through February 24, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25F1337, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,355,218 units of Fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The contract is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $4,402.00, and an ultimate...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,780.36, is a Delivery Order contract with a Firm Fixed Price pricing type. It covers the supply of 4567104529 FENOFIBRATE 145 MG TABLET 500S, with an Ultimate Completion Date of January 31, 2025. The contract is not designated as a Set-Aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,407.74, is a Firm Fixed Price Delivery Order for the supply of Fenofibrate 48 mg Tablet Unit Dose (30s). The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Fenofibrate 145 mg tablets in 90-count packages. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $22,636.70, and has a completion date of February 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Fenofibrate 145 mg tablets to the Defense Logistics Agency (DLA). The $3,126.59 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 1, 2023, with a completion date of November 2, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued up to $999,999,999.00...
This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL25Q, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,553.99 firm fixed-price delivery order is for the supply of 4563689488 Fenofibrate 145 mg tablets, with a completion date of February 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Fenofibrate 145 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,372.39 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 17, 2023. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...